XOMA – xoma corporation (US:NASDAQ)
Stock Stats
News
12/5
09:00 am
xoma
Medium
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
11/26
02:24 pm
xoma
Low
XOMA Royalty (NASDAQ:XOMA) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
11/21
07:45 am
xoma
Medium
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
11/20
06:03 am
xoma
Medium
XOMA Royalty (NASDAQ:XOMA) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/14
01:19 pm
xoma
Low
XOMA Royalty (NASDAQ:XOMA) was upgraded by analysts at Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
11/12/2025
07:30 am
xoma
-3.1%
BEAT
8/13/2025
07:30 am
xoma
7.2%
BEAT
5/13/2025
07:30 am
xoma
8.2%
BEAT
12/5
09:15 am
xoma
Medium
Form 8-K XOMA Royalty Corp For: Dec 05
11/21
08:04 am
xoma
Medium
Form 8-K XOMA Royalty Corp For: Nov 21
11/12
07:46 am
xoma
Medium
Form 8-K XOMA Royalty Corp For: Nov 12
11/12
07:46 am
xoma
Medium
Form 10-Q XOMA Royalty Corp For: Sep 30
10/3
05:25 pm
xoma
Medium
Form 8-K XOMA Royalty Corp For: Oct 03
Show more
Top News Gainers
12/20 XOMA Announces Closing of Rights Offering 13.4%
3/23 Form 4 XOMA Corp For: Mar 20 Filed by: Neal James R 10.7%
11/5 Q3/2019 9/30/2019 EPS 0.200 ZacksConsensus -0.480 ActVsEst 0.680 - Beat 7.3%
3/16 Form 4 XOMA Corp For: Mar 13 Filed by: Neal James R 7.3%
2/13 Form SC 13D/A XOMA Corp Filed by: BIOTECHNOLOGY VALUE FUND L P 6.7%
3/27 Form 4 XOMA Corp For: Mar 25 Filed by: BVF PARTNERS L P/IL 6.2%
5/14 Form 4 XOMA Corp For: May 10 Filed by: VAN NESS W DENMAN 5.9%
12/5 Iscalimab (CFZ533) Update 4.9%
5/20 Form 4 XOMA Corp For: May 16 Filed by: Kosacz Barbara 3.6%
2/15 XOMA Corp (NASDAQ: XOMA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.3%
Top News Decliners
3/14 XOMA Corp (NASDAQ: XOMA) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. -16.4%
3/17 Form 3 XOMA Corp For: Mar 13 Filed by: BVF GP HOLDINGS LLC -10.6%
5/6 Form 10-Q XOMA Corp For: Mar 31 -8.5%
5/24 XOMA Corp (NASDAQ: XOMA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -7.7%
3/10 XOMA Corp (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock. -6.2%
2/22 XOMA Corp (NASDAQ: XOMA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -6.1%
3/9 Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement -5.7%
8/6 Form 8-K XOMA Corp For: Aug 06 -5.7%
9/20 Form 4 XOMA Corp For: Sep 18 Filed by: Neal James R -4.9%
11/19 XOMA Announces Proposed Rights Offering -4.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3